Systemic Anti-Cancer Therapies in Neuroendocrine Tumor Patients Impair Nutritional Status

#2098

Introduction: Malnutrition is a clinical relevant problem in NEN-patients (pts) independently influencing overall prognosis, particularly in pts undergoing chemotherapy (CTx). A poor nutritional status (NS) in pts of all WHO-grades was associated with a significantly shorter long-term outcome

Aim(s): This prospective observational longitudinal study investigates the influence of a systemic medical treatment initiation due to progressive disease on NS in NET G1/G2 pts

Materials and methods: Subjective Global Assessment (SGA), body weight (BW), bioelectrical impedance analysis (BIA) and anthropometry parameters were regularly assessed before and during therapy

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Pevny S, Maasberg S, Karber M, Knappe-Drzikova B, Weylandt K,

Keywords: nutritional status, malnutrition, chemotherapy, somatostatin analogues, everolimus, NETG1/G2, survival,